Twin Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Twin Capital Management's BSX Position: Q2 2026 in Review
Twin Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 33,420 shares — an estimated $2.1M sold.
Twin Capital Management first reported a position in BSX in Q2 2013 and held it in 14 quarters. The position peaked at $4.46M in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Twin Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Twin Capital Management sold 33,420 Boston Scientific shares in Q2 2026, an estimated $2.1M.
- Twin Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 14 quarters.
- Twin Capital Management's Boston Scientific position peaked at $4.46M in Q2 2025.
- 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Twin Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.